Dr. Dionysis Papadatos-Pastos

• Dr. Dionysis Papadatos-Pastos is an experienced Medical Oncologist specialising in lung cancer, mesothelioma, and thymic tumours.
• His sub-specialist interests include immunotherapy and targeted therapies for non-small cell lung cancer, small cell lung cancer, and mesothelioma.
• He provides treatments including immunotherapy, targeted therapy, chemotherapy, and participation in early-phase clinical trials.
• He completed his Medical degree from the University of Athens with distinction, a PhD in Medical Oncology (focusing on biomarkers) in 2012, and holds a Diploma in Medical Oncology from the Institute of Cancer Research, University of London.
• He is a Consultant Medical Oncologist at University College London Hospitals (UCLH) and The Princess Alexandra Hospital NHS Trust since 2016.
• Dr. Papadatos-Pastos leads the lung cancer program at the CRUK UCL Clinical Trials Centre and co-chairs the London Clinic Lung Cancer Multidisciplinary Team (MDT).
• He is a Member of the Royal College of Physicians (RCP), American Society of Clinical Oncology (ASCO), and British Medical Association (BMA).
• Dr. Dionysis Papadatos-Pastos is Chief Investigator in multiple academic and commercial clinical trials focusing on novel targeted therapies and combinations of immunotherapy agents.
• He has authored multiple peer-reviewed publications and is actively involved in clinical education and research presentations at national and international oncology conferences.

Conditions treated by Dr. Dionysis Papadatos-Pastos

• Non-small cell lung cancer
• Small-cell lung cancer
• Mesothelioma
• Thymoma
• Thymic cancer

Area of Interest

• Medical oncology

Qualification

• MRCP(UK)
• MD: Graduated from the University of Athens with distinction.
• Diploma in Medical Oncology: Institute of Cancer Research, University of London.
• PhD in Medical Oncology: Awarded in 2012 with First Class honours.

Work Experiences